Clinical Trial Update: Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating individualized adaptive radiotherapy for HPV-associated high-risk oropharyngeal cancer; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Oropharynx Cancer, HPV-Related Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING